Long-Awaited Nationwide Opioid Settlement To Move Forward For Teva
Participation Has Been Confirmed For 48 Of The 50 US States
Executive Summary
Teva has all but two US states on board for its long-hoped-for nationwide settlement to resolve opioid-related claims against the firm.
You may also be interested in...
Teva Quits PhRMA As Financial, Policy Challenges Loom For The Brand/Generic Hybrid Giant
With a leadership position in the US generics association and a new CEO focused on how to reallocate resources, Teva leaves the brand trade association after a review of the ‘effectiveness and value of engagements.’
Five Big Legal Stories From 2022
Generics Bulletin looks back at a selection of the most significant legal stories from 2022, including a major victory in the UK on the Eliquis blood thinner giant and continued action on generic label carve outs, which has the potential to reverberate through the US industry.
2022 Hires Reflect Global Challenges And Opportunities
Executive changes in 2022 reveal how the industry is adjusting to a volatile post-COVID environment.